EQS-News: APONTIS PHARMA AG / Key word(s): Preliminary Results/Annual Results APONTIS PHARMA with successful financial year 2022: Revenue and EBITDA forecast slightly exceeded according to preliminary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results